Table 2 |
||||||||
|
Frequency of individual ongoing symptoms at inclusion (%) |
||||||||
|
Lille |
Lyon |
La Verrière |
St Etienne |
Dublin |
Lisbon |
Granada |
p |
|
|
N = 47* |
N = 45 |
N = 27 |
N = 50 |
N = 64 |
N = 50 |
N = 84 |
||
|
|
||||||||
|
Psychotics symptoms |
80.4 |
93.2 |
92.6 |
100.0 |
68.8 |
100.0 |
100.0 |
0.97 |
|
Slowness/under-activity |
37.0 |
65.9 |
81.5 |
68.0 |
45.3 |
62.0 |
71.6 |
.04 |
|
Side effects. dyskinesia |
28.3 |
43.2 |
51.9 |
40 |
26.6 |
48.0 |
27.2 |
0.55 |
|
Neurotic symptoms |
19.6 |
43.2 |
22.2 |
6.0 |
9.4 |
16.0 |
23.5 |
.009 |
|
Physical symptoms |
13.0 |
31.8 |
33.3 |
42.0 |
6.3 |
14.0 |
7.4 |
0.89 |
|
Dangerous behaviour |
15.2 |
29.5 |
22.2 |
32.0 |
15.6 |
24.0 |
19.8 |
0.39 |
|
Embarrassing behaviour |
15.2 |
27.3 |
11.1 |
12 |
9.4 |
40.0 |
24.7 |
0.96 |
|
Distress |
21.7 |
38.6 |
7.4 |
34.0 |
12.5 |
28.0 |
38.5 |
0.60 |
|
Alcohol |
13.0 |
4.5 |
11.1 |
10.0 |
10.9 |
16.0 |
21.0 |
0.01 |
|
Drugs |
0.0 |
4.5 |
3.7 |
4.0 |
4.7 |
6.0 |
7.4 |
0.86 |
|
|
||||||||
|
*NFCAS missing for one patient |
||||||||
|
Kovess-Masféty et al. BMC Psychiatry 2006 6:39 doi:10.1186/1471-244X-6-39 |
||||||||
